Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Scaling New Heights: DeFiQuant's Crypto Bot Sets Benchmark for Automated Trading
-
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
-
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing
-
INNOVATE Corp. Announces Rights Offering for Common Stock
-
Cardiff Oncology to Present at the Cowen 44th Annual Health Care Conference
-
BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer
-
Perspective Therapeutics to Participate at Upcoming Investor Conferences
-
SIMONE BILES, JAMAL MURRAY AND COCO GAUFF LEAD THE NOMINATIONS FOR 2024 LAUREUS WORLD SPORTS AWARDS
-
Lirum Therapeutics Presents Positive Data on LX-101, a Novel Clinical-Stage Targeted Therapy, at the 2024 ESMO Targeted Anticancer Therapies Congress; Highlighting LX-101’s Potential in IGF-1R Promi
-
Ekso Bionics to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
-
Tempest to Present at the 44th Annual TD Cowen Healthcare Conference
-
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over
-
Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
-
NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in March
-
Pliant Therapeutics to Participate in Upcoming Investor Conferences
-
Matinas BioPharma Provides Positive Outcomes Update on the MAT2203 Compassionate/Expanded Use Access Program, Including Multiple Patients with Complete Clinical Resolution
-
Biora Therapeutics Announces Successful Completion of Single-Ascending Dose (SAD) Cohorts of Phase 1 Clinical Study of BT-600
-
Interstellar Communication Holdings Welcome New Board Member
-
Monarch Private Capital Finances the Rehabilitation of Historic Landmark in New Orleans
-
Lightspeed to Participate in Upcoming Investor Conferences
-
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
-
Equipment Leasing and Finance Association’s Survey of Economic Activity: Monthly Leasing and Finance Index
-
Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference
-
Aligos Therapeutics To Participate in the Leerink Partners Global Biopharma Conference 2024
-
Disclosure of trading in own shares from February 19, 2024 to February 23, 2024
-
Velcan Holdings: Share buyback program - weekly statement
-
MoonLake Immunotherapeutics Announces Positive Feedback from both FDA and EMA on Regulatory Path for the Phase 3 Program of the Nanobody® sonelokimab (SLK) in Hidradenitis Suppurativa (HS)
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
ASML reports transactions under its current share buyback program
-
eQ Plc has released the 2023 Annual Report
-
red violet to Announce Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
-
Microchip Launches New dsPIC® DSC-Based Integrated Motor Drivers that Bring Controllers, Gate Drivers and Communications to a Single Device
-
Save Foods Navigates Brazilian Regulation and Commences Commercial Activity Through Exclusive Local Distributor
-
iZIP.AI Unveils Groundbreaking AI Crypto Chatbot, Automated Trading Signals, and Comprehensive Market Analysis Platform
-
iZIP.AI Unveils Groundbreaking AI Crypto Chatbot, Automated Trading Signals, and Comprehensive Market Analysis Platform
-
Boussard & Gavaudan Investment Management LLP: Form 8.3 - Network International Holdings Plc
-
Fairfax Announces Acquisition of Additional Orla Shares
-
New Journey in Compliance: BAORUI Proudly Acquires the US MSB License, Marking a Financial Milestone
-
Trailbreaker Resources Expands Land Package and Receives Drill Permit for Liberty Copper Property
-
iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka
-
Cognition Therapeutics to Present at the TD Cowen Health Care Conference
-
NFI subsidiary Alexander Dennis’ next-gen Enviro400EV confirmed as the most efficient battery-electric double-decker tested via Zemo in the UK
-
Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2023 Results; Sets 2024 Guidance
-
Kura Oncology Doses First Patient in KOMET-008 Trial of Ziftomenib in Combination with Standards of Care, Including FLT3 Inhibitor, in Acute Myeloid Leukemia
-
Aterian Further Strengthens Its Balance Sheet With Extension Of Its Credit Facility
-
Blackwells Capital Releases its Vision for the Future of Technology at Disney
-
Lilium Gears Up for Production of the Lilium Jet’s Revolutionary Electric Propulsion Units
-
TINA.org Investigation Finds Pervasive Deceptive Earnings Claims in MLM Industry
-
AirBoss Announces Corporate Update and Preview of Annual 2023 Results
-
Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmac
